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1. Introduction  
Posttraumatic stress disorder or PTSD is an extreme psycho-physiological response disorder 
that may occur in individuals who are exposed to a potentially traumatic event that can 
involve the subjectively profound threat of loss… of life or limb. To receive a PTSD diagnosis, 
reactions to the catastrophic or traumatic stressor must involve profound fear, helplessness, 
or horror. Furthermore, such individuals have to experience symptoms from three separate 
yet co-occurring symptom clusters. These clusters or domains include: 1) intrusive 
recollections or the re-experiencing of the event with accompanied intense psychological 
distress or physiologic reactivity; 2) persistent avoidance of activities, thoughts as well as 
feelings associated with the traumatic event; and, 3) increased or extreme arousal that may 
include an exaggerated startle response, hypervigilance, or insomnia (American Psychiatric 
Association, 1994; Uddin et al., 2010) To justify a PTSD diagnosis, symptoms must be 
present for at least one month, and impair an individual’s interpersonal, occupational, or 
social functioning (American Psychiatric Association, 1994). PTSD has been described as a 
specific phenotype that develops as the result of a failure to contain the normal stress 
response (Yehuda & LeDoux, 2007), resulting in dysregulation of the hypothalamic–
pituitary–adrenal or HPA axis, a major stress response system of the body that interacts 
with the immune system to maintain homeostasis (Wong, 2002). PTSD-affected and 
unaffected individuals have distinct expression patterns in genes involved in immune 
activation (Segman et al., 2005; Zieke et al., 2007), and in genes that encode neural and 
endocrine proteins (Segman et al., 2005; Yehuda et al., 2009). Above all, PTSD is both an 
external and internal experience; that is, PTSD is an external catastrophic or traumatic event 
and an internal psycho-physiological experience.  
1.1 Trauma goes public 
Once upon a time in the west, PTSD was known as a psychiatric disorder associated most 
frequently with Vietnam War veterans as exemplified by the label of post-Vietnam syndrome 
(Friedman, 1981). This, despite the fact that similar war-related traumatic experiences of 
American soldiers who served in Vietnam can be found as far back as Homer's epic account 
of Achilles in The Iliad (Shay, 1994). Yet, while long-term psychiatric conditions were 
witnessed in previous war veterans, PTSD failed to permeate public consciousness until 
Vietnam. Indeed, Mezey and Robbins point out that PTSD has socio-economic and political 
implications since veterans are the group most associated with this disorder (2001). With 
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Vietnam, PTSD exploded into popular culture, becoming a subject for the general public in 
many films: Apocalypse Now (1979), Born on the Fourth of July (1989), Casualties of War (1989), 
The Deer Hunter (1978), First Blood (1982), Full Metal Jacket (1987), Good Morning, Vietnam 
(1987), the Green Berets (1968), Hamburger Hill (1987), Hanoi Hilton (1987), Jacob’s Ladder 
(1990), the Killing Fields (1984), and Platoon (1986) (Bealle, 1997). In 1980, posttraumatic stress 
disorder (PTSD) was recognized as an official classification of a psychiatric disorder in the 
third edition of the Diagnostic and statistical manual of mental disorders (DSM-III) (American 
Psychiatric Association, 1980). This inclusion of PTSD in DSM-III basically served to 
legitimize a psychological disorder by re-labeling what had been described in the forgotten 
past as “soldier’s heart,” "shell shock," “railway spine, "war neurosis," "traumatic neurosis," 
"combat trauma," or "combat fatigue" (Bealle, 1997). The growth of psychiatric epidemiology 
enabled PTSD investigations to include samples of general populations in the United States 
and in other countries. In the U.S. during the past decade, trauma “goes public” was 
nowhere more evident than in the aftermath of 9/11 with the attack on the Twin Towers. 
The public traumatic event of “9/11 changed the picture of PTSD, and transformed it from 
being simply a mental disorder that psychiatrists deal with to a public health issue;” that is, 
“for the first time, psychiatric leaders pondered how factors such as media coverage, 
community cohesion, and poverty may affect the public’s mental health when mass disaster 
strikes” (Brandt, 2011; Schuster et al., 2001). 
2. PTSD in the context of cancer 
The potentially traumatic and protracted nature of cancer’s disease course and treatment 
received acknowledgment in 1994, when the Diagnostic and statistical manual of mental 
disorders, fourth edition (DSM-IV), revised events that may precede a posttraumatic 
response. Specifically, “life threatening illness” was added to the criteria as a potentially 
precipitating event for the development of posttraumatic stress disorder or PTSD (American 
Psychiatric Association, 1994). Previously, criteria has centered upon acute events such as 
war, natural disasters, automobile accidents, and rape. This new inclusion of a chronic and 
possible terminal disease process into the diagnostic criteria, indeed, was a significant 
change as to precipitating events associated with PTSD. First, diagnostic criteria for PTSD 
within the context of malignant disease will be summarized. Then, a review of the literature 
with current PTSD prevalence will follow with prevalence rates for identified cancer types 
and age groups as adequate data and number of studies permit, risk factors, and lastly, 
concluding comments. 
2.1 Trauma by any other name  
Before reviewing diagnostic criteria, the debate about malignant illness as a traumatic event 
needs to be addressed (e.g., Kwekkeboom & Seng, 2002; Palmer et al., 2004), in order to 
highlight that variation is not negation of a disorder’s existence. Events such as rape, assault, 
or natural disasters, etc., tend to be singular events restricted to a finite period during which 
the external agent ceases to be acutely present in real living time. It may be argued that 
cancer is ambiguous as a stressor event, for malignancy does not fit neatly into an objective 
timeline with a discrete beginning and ending. One may ask, what event truly was the 
stressor event? Was it the public confirmation of the diagnosis, of which, one may have 
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already decided privately was cancer?... Was it a procedure such as the biopsy?...Was it a 
treatment regimen? Or was it side effects from treatment or the disease? Regardless, the 
bottom line is that the threat of death is real and present at all times. Secondly, another 
variation of the posttraumatic experience related to cancer is the time zone of traumatic-
inducing reality. Traditional stressor events, which are thus re-experienced, obviously are 
located in the past, and are primarily retrospective trauma. Cancer-related PTSD, however 
can be viewed as being bidirectionally traumatic in terms of subjective time: retrospective 
with memories of the past, yet also prospectively traumatic with a truncated future that is 
equally as threatening, helpless, and horrifying. The integrity of self is threatened because 
self is in clear and present---and future danger of not existing. The traumatizing reality 
that one’s long-term plans, hopes or dreams for the future such not seeing a child 
graduate from high school, get married, etc., or worse---that one will die an agonizing and 
painful death are forward experiences in the timeline of trauma that personifies a 
foreshortened future.  
Thirdly, another variation of cancer-related PTSD is the fact that the traumazing agent or 
perpetrator is not external; rather, it is internal in the form of a biological, patho-
physiological disease with threat of recurrence, which can lead to a sense of ambivalent 
betrayal of self. The rude reality is that trauma is experienced in the past, in the present, and 
in the future tense of experiencing. Moreover, being a cancer survivor does not dispell 
distress of life-threatening trauma or mean that one is safe and sound. In addition to anxiety 
and depressive symptomatology, pervading concerns about prognosis, treatment options 
and effects, or ruminating fears about upcoming doctor appointments and disease 
recurrence, are all common sources of distress that can plague cancer patients in 
survivorship long after treatment has ended (Andrykowsk, et al., 2008; Montgomery et al., 
2003). For example, acute or sub-acute symptoms may erupt with each doctor’s visit, routine 
check-up, or getting a mammogram, etc., from post-traumatic cues of a patient’s previous 
cancer experience. Unfortunately, routinized triggers can become embedded within the 
healthcare system, to where a cycle of nosocomial re-triggering or institutional re-
traumatization is conceivably possible. Indeed, the original traumatic-inducing event may 
be lost among the chronic cascading triggers---even in the absence of recurrence or a new 
primary site of malignancy. 
The addition of “life threatening” illness to official PTSD criteria is exactly that---life-
threatening. The spontaneous potential of traumatic triggers and the pervasive pain from 
living a disrupted life with PTSD---be it from a traditional event or a life-threatening 
illness with recurrence---is equivocal when it comes to human physical and mental 
suffering. In sum, cancer-related PTSD is no less valid or more ambiguous than traditional 
stressor events, for trauma by any other name---cancer--- is trauma despite variation of 
etiology.  
3. DSM in brief: Diagnostic criteria for PTSD 
A brief review of general symptom clusters (see Table 1) (Friedman, 2006) and diagnostic 
criteria A – F (Table 2) (American Psychiatric Association, 1994, 2000), will be presented 
with tables to make the information more user-friendly. In order to be diagnosed with PTSD 
due to the potentially [precipitating] traumatic event of being diagnosed with a malignant 
disease process, all of the six criteria, that is, A – F, must be satisfied.  
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Cluster Specific Symptoms
Reexperiencing  Intrusive recollections 
 Traumatic nightmares 
 Flashbacks 
 Trauma-evoked psychological distress 
 Trauma-evoked physiological reactions 
Avoidant/Numbing  Avoiding trauma-related 
thoughts/feelings 
 Avoiding trauma-related 
activities/places/people 
 Amnesia of trauma-related memories 
 Diminished interest 
 Detached or estranged feelings 
 Restricted range of affect 
 Sense of foreshortened future
Hyperarousal  Insomnia 
 Irritability 
 Difficulty in focusing/concentrating 
 Hypervigilance 
 Exaggerated startle reaction
Table 1. Symptom Clusters for PTSD (Friedman, 2006) 
  
Criterion A: Stressor Exposed to a traumatic event in which both of the 
following were present:  
A1. Person experienced, witnessed or was 
confronted by an event that involved actual or 
threatened death or serious injury, or a threat to 
the physical integrity of self or others. The 
traumatic event includes diagnosis of a life-
threatening illness such as cancer that threatened 
one’s life and/or physical integrity; involved 
either direct personal experience (such as being 
the patient) witnessing, confronting, or learning 
about the illness experience through a family 
member or close friend—which may pose a threat 
to the integrity of a significant other  
A.2 Response involved intense fear, helplessness 
or horror  
Criterion B: Intrusive Recollection  The traumatic event is re-experienced persistently 
in at least one of the following ways:  
B1. Recurrent and intrusive distressing 
recollections of the event, including images, 
thoughts, or perceptions; thus, a distressing cancer 
event such as a diagnosis, has occurred for one to 
have distressing recollections about such an event 
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B2. Recurrent distressing dreams of the event  
B3. Acting or feeling as if the traumatic event were 
recurring with sense of re-experiencing it again; 
dissociative flashbacks  
B4. Intense psychological distress at exposure to 
internal or external cues that symbolize or 
resemble an aspect of the traumatic event  
B5. Physiological reactivity at exposure to 
internal/external cues that symbolize or resemble 
an aspect of traumatic event 
Criterion C: Avoidant/Numbing
 
Persistent avoidance of stimuli associated with the 
trauma and numbing of general responsiveness 
(not present before the trauma, in this case, 
cancer) as indicated by three or more of the 
following:  
C1. Efforts to avoid thoughts, feelings, or 
conversations associated with the trauma  
C2. Efforts to avoid activities, places or people 
that arouse recollections of the trauma  
C3. Inability to recall an important aspect of the 
trauma  
C4. Markedly diminished interest or participation 
in significant activities  
C5. Feeling of detachment or estrangement from 
others  
C6. Restricted range of affect (for example, unable 
to have loving feelings)  
C7. Sense of a foreshortened future, (does not 
expect to have a career, children, marriage, or a 
normal lifespan 
Criterion D: Hyperarousal Persistent symptoms of increased arousal (not 
present before the trauma, in this case, cancer) as 
indicated by two or more of the following:  
D1. Difficulty falling or staying asleep  
D2. Irritability or outbursts of anger  
D3. Difficulty concentrating  
D4. Hypervigilance  
D5. Exaggerated startle response 
Criterion E: Duration Duration of the disturbance (symptoms in B, C, & 
D) is more than one month.  
Criterion F: Functional Significance The disturbance causes clinically significant 
distress or impairment in social, occupational or 
other important areas of functioning. 
Table 2. DSM Criteria for PTSD (American Psychiatric Association, 1994, 2000) 
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3.1 Criteria A - C 
The DSM’s first criterion, A, relates to PTSD’s conceptualization as a stress-related response 
syndrome where the person experienced an event that threatened his/her life or physical 
integrity (American Psychiatric Association, 1994, 2000). Also, this criterion includes 
vicarious traumatization, that is, the witnessing of traumatic events as well as hearing 
traumatic news or unexpected occurrences about loved ones. For example, related PTSD 
investigations have expanded to include not only the patients themselves, but also, loved 
ones affected by the experience of cancer in another, for example, parents of children 
diagnosed with malignancy as well as partners, siblings or significant friends of cancer 
patients (e.g., Alderfer et al., 2010; Poder, Ljungman, & von Essen, 2008). 
Criterion B involves persistent re-experiencing of the cancer experience (including the 
intrusive thoughts of symptoms, the way diagnosis was communicated, impending death or 
experience of review visits), for example, recurrent and intrusive memories or images in the 
form of flashbacks or nightmares. Noticeable physical reactions may present, such as 
breaking out in a sweat, feeling light-headed or nauseous, having palpitations, or breathing 
gets fast and shallow. Criterion C is persistent avoidant or emotional numbing strategies 
that serve the purpose of blocking internal or external stimuli reminiscent of the traumatic 
event, such as avoiding certain people, places, or perhaps even the music playing in the 
background when the event was occurring.  
3.2 Criteria D - F 
Criterion D involves persistent hyper-physiological arousal and-or anxiousness that were 
not present before the diagnosis or experience of cancer, and might include sleeping 
problems, irritability and anger outbursts. Another form of arousal unique to cancer-related 
PTSD is body symptom hypervigilance or being on guard for signs of another tumor. 
Criterion E indicates that the duration of such symptoms has persisted for a period of at 
least one month following the cancer-related traumatic event (e.g., being told the diagnosis 
or given a poor prognosis, etc.), thereby, distinguishing it from acute stress disorder. Finally, 
Criterion F indicates the extent to which the symptoms impair domains of life functioning, 
for example, relational or occupational. Please refer to Table 2. 
4. PTSD and adult cancer  
In general, assessing prevalence rates of PTSD in adults with cancer have consisted 
primarily of breast cancer patients including a wide range of time between diagnosis and 
treatment, from several days to over a decade.  
4.1 Current search strategy 
For the current investigation, a literature search was conducted for PTSD prevalence rates in 
current adult cancer patients and cancer survivors via the ISI Web of Knowledge, Medline and 
PsycINFO databases, and the references of retrieved articles. The search considered only 
studies published in English. The main search terms were posttraumatic, PTSD, cancer, 
cancer patients, prevalence, prevalence rates, in various combinations as needed. The search 
strategy consisted of several levels of filtering out articles not relevant to the purposes here. 
The articles considered useful for the aim of this paper included studies where current 
prevalence rates for PTSD were ssessed, and identification of posttraumatic cases were 
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based on official DSM guidelines, that is, DSM criteria had been applied. Also included were 
studies where participants were current patients at the time of data collection or were cancer 
survivors of 60 months (the five-year marker) or less since the end of treatment; this was 
done in an effort to reduce the potential wide range of survivor time variation (i.e., 
survivors of 13-years, 2-years, etc). No limitations were placed on the number of 
participants, the study design, or whether a control group was included; studies reporting 
qualitative data were excluded.  
4.2 Results 
A total of 11 studies met criteria, which were based on interview data collection (See  
Table 3). The current PTSD diagnostic gold standard remains a clinical interview that is 
based on the predefined criteria in the DSM (American Psychiatric Association, 1994).Three 
of the studies involve participants with a mixture of cancer diagnoses excluding breast 
malignancy (Akechi et al., 2004; Kangas et al., 2005; Widows et al., 2000). The remaining 
eight studies investigating adult cancer-related PTSD include breast cancer patients at 
various points in the disease process (Andrykowski et al., 1998; Gandubert et al., 2009; 
Green et al., 1998; Luecken et al., 2004; Mehnert & Koch, 2007; Mundy et al., 2000; Okamura 
et al., 2005; Shelby et al., 2008). Despite advances in breast cancer diagnosis and treatments, 
it remains a monumental stressor in these women’s lives that continues to elicit greater 
distress than any other medical diagnosis (Shapiro et al., 2001). This distress is now 
recognized as an integral component of a patient’s clinical presentation (Bultz & Carlson, 
2006); additionally, depression, anxiety, and posttraumatic stress disorder (PTSD) 
symptoms occur somewhere between 20 and 66% of women in the first 12 months alone 
after their diagnosis (Burgess et al., 2005; Vos et al., 2004). Such psychological difficulties in 
response to the challenge of cancer appear congruent with certain pre-cancer factors that 
may set the stage for patient vulnerability. Specifically, posttraumatic stress disorder cases 
have been found to be distinguished by a previous history of violent traumas as well as 
psychological problems such as anxiety disorders that predate the diagnosis of cancer (e.g., 
Shelby et al., 2008).  
The sample sizes in the eight breast cancer studies range from 37 to 160 participants with a 
mean of 93 participants and the median of 78 participants. Prevalence rates for current 
cancer-related PTSD range from 0% to 16.2% with a mean of 4.6% and a median of 2.75%. 
Sample sizes for the three studies of mixed cancer types range from 82 to 209; the mean of 
participants in these studies is 131 participants with a median of 102 participants. The  
prevalence rates for current cancer-related PTSD in these studies range from 0% to 22% with 
a mean prevalence rate of 9% and a median of 5%.  
In sum, these findings are congruent with previous estimates of current cancer-related PTSD 
prevalence in adult patients, that is, in women with breast cancer or mixed samples of 
gender with head, neck or lung cancer ranging from 0 to 32% (Hamann et al., 2005). Several 
points need to be acknowledged. First, the majority of studies---as tends to be the case in the 
area of psychosocial oncology literature---involved women with breast cancer. Thus, most of 
the current knowledge regarding PTSD in the context of malignant disease is based upon 
this cancer population with frequently low sample sizes. Basically, this means that caution is 
needed, for generalizability of such results do not apply to other disease populations or to 
those with other types of cancer. Also, the majority of these investigations were cross-
sectional studies with time variation as to time of assessment from either diagnosis or 
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treatment. Cross-sectional data prohibits clinical understanding of the development as well 
as the trajectory patterns of PTSD in those with cancer. The relative lack of prospective or 
longitudinal data is needed to inform clinicians early in the disease process so that highly 
distressed patients may be identified and helped as early as possible with this life-
threatening illness. Lastly, cross-sectional research does little in the way of determining risk 
factors relevant to later survival time or predicting the delayed onset of posttraumatic stress. 
Attention now turns to investigations assessing PTSD in strictly male samples with 
diagnosed malignancy.  
 
Study  Design Sample Time Period 
PTSD 
Prevalence 
Akechi  
et al. (2004) 
Cross-
sectional 
n = 209; males/ 
females; mixed 
cancer diagnosis 
25 months post-
dx 
0% (only 100 
participants 
assessed) 
Andrykowski  
et al., (1998) 
Cross-
sectional 
n = 82 females; breast 
37 months post-
treat 
6% current  
Gandubert  
et al., (2009) 
Cross-
sectional 
n = 144; female; breas 1-3 years post-dx 4.9% current 
Green  
et al., (1998) 
Cross-
sectional 
n = 160 females; 
breast  
6.5 months post-
treat 
2.5% current 
Kangas  
et al., (2005) 
Longitudinal 
n = 82; 
males/females head, 
neck, lung cancer 
6 months post-dx 22% current  
Luecken  
et al., (2004) 
Cross-
sectional 
n = 71;  
females; breast 
1-6 months post-
dx 
3% current  
Mehnert & 
Koch, (2007) 
Cross-
sectional 
n = 127;  
females; breast 
15 days post-dx 
of initial cancer 
(77%) ;  
or recurrent 
malignancy 
(23%), 0-67 days 
2.4% current 
Mundy  
et al., (2000) 
Cross-
sectional 
 n = 37;  
females; breast 
> 100 days post-tx 0% current 
Okamura  
et al., (2005) 
Cross-
sectional 
n = 50; females; 
breast recurrence 
1-6 months post-
dx recurrence 
2% current 
Shelby  
et al., (2008) 
Longitudinal 
n = 74;  
females; breast 
dx/surgery – 18 
months 
1.6% current  
Widows  
et al., (2000) 
Cross-
sectional 
n = 102; 
males/females; 
cancer not specified  
20.4 month post-
bone marrow 
transplant 
5% current 
Table 3. Summary of select cancer studies 
5. PTSD: Men with malignant disease 
While a plethora of studies have assessed prevalence rates for women breast cancer and/or 
mixed gender studies, a paucity of research exists as to the prevalence rates in strictly male 
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samples with malignant processes. This is surprising since survivors of prostate cancer 
continue to grow as well as the fact that psychological distress in response to receiving a 
prostate cancer diagnosis is a recognized phenomenon (Anastasiou et al., 2011; Gwede et al., 
2005; Namiki et al., 2007). Furthermore, psychological distress in prostate cancer patients 
has been found to be related to the following: stage of disease, shorter time since diagnosis, 
and treatment options or decisions (Gwede et al., 2005). For men, receiving the diagnosis of 
malignant disease has been found to be associated with responses that include anxiety, 
denial or distress (Kronenwetter et al., 2005).  
Distress related to decision-making is a common experience among men after the diagnosis 
of prostate cancer; specifically, reports indicate that around 63% report high decision-related 
distress persisting the first year after treatment for 42% of all men (Steginga et al., 2008). 
Also, an increased manifestation of traumatic stress symptoms has been found in some cases 
of newly diagnosed men with localized prostate cancer before the beginning of treatment 
(Bisson, 2007); on the other hand, low emotional distress has been documented as being 
present even 2 years after a radical prostatectomy (Perez et al., 2002). Follow-up of males 
during the disease course of their prostate cancer show that males with prostate cancer may 
suffer with long-term physical and psychological consequences---to the point of affecting 
their quality of life (Penson, 2007; Sanda et al., 2008). Indeed, accumulating data within the 
past 15 years has produced a body of literature investigating health related quality of life 
(HRQOL) outcomes pertaining to localized prostate cancer (Penson, 2007). This stands in 
contrast to empirical exploration regarding adjustment in such male cancer survivors. 
Unfortunately, the literature does not demonstrate ample descriptive investigations as to the 
course of psychological adjustment for men who have been diagnosed with and treated for 
prostate cancer (Steginga et al., 2004). No studies could be identified that specifically 
assessed PTSD in men with testicular or lung cancer. 
A recent study by Anastasiou and colleagues (2011), believed to be the only study that has 
focused on investigating the presence of acute posttraumatic stress disorder (PTSD) in men 
with malignant disease necessitating a radical prostatectomy, assessed symptoms in 15 men 
one month after surgery. The men completed the Davidson Trauma Scale rather than being 
assessed by interview. Analyses determined that 26.7% of the men’s scores met scale criteria 
for acute PTSD, which was found to be independent of the patient’s educational level. In 
sum, despite the fact that prostate cancer is the second most frequently diagnosed cancer in 
developed countries, and the third most common cause of death in men (Damber & Aus, 
2008), little is known about the psychological ramifications for prostate cancer patients after 
surgery (Burns & Mahalik, 2008; Namiki et al., 2007; Steginga et al., 2004).  
6. PTSD and pediatric cancer 
The present search revealed few reports of cancer-related PTSD in pediatric patients.  
6.1 Results 
The search revealed only two studies assessed within the five-year mark with data 
regarding cancer-related PTSD (Landolt et al.,1998; Pelcovitz et al., 1998). However, due to 
the lack of studies, a third study that assessed PTSD at 5.3 years, was included (Kazak et al., 
2004). The participants were less than 18 years of age at the time of these investigations, 
which all consisted of mixed cancer diagnoses. The sample sizes were 150, 7, and 23; the 
mean sample size was 60 with a median of 23 participants. The prevalence rates in these 
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studies for current cancer-related PTSD were documented as ranging from 4.7% to 71%; the 
mean prevalence rate was 31% with a median of 17%. It must be pointed out that the 
prevalence rate finding of 71% comes from a study with a small sample size of only seven 
participants who were identified as “newly diagnosed.” Therefore, the possibility that this 
assessment may have occurred within the first month of diagnosis calls into question the 
appropriateness and validity of these data. Unfortunately, the small number of studies in 
this area of current PTSD prevalence as well as the questionable data provided limit the 
scope of this review; therefore, conclusions about prevalence rates in this population are 
prohibitive at this time.  
7. PTSD: All in the family 
Each year in the United States, approximately 14,000 children are diagnosed with cancer 
(Ries et al., 2008). The diagnosis of cancer is a traumatic experience for both the child and the 
family, which understandably causes a great of deal of disruption within the family system. 
The following review will encompass literature regarding posttraumatic stress among 1) 
parents of children with cancer, 2) the bereaved following the death of a cancer patient, and 
3) the siblings of children diagnosed with cancer. 
7.1 Parent and child 
Having a child diagnosed with cancer is one of the most severe stressors that parents could 
possibly ever experience; the threat of their child’s death and feelings of helplessness 
converge as the entire family faces the uncontrollable enemy of cancer (Kazak, 1998; 
Patterson et al., 2004). The change of the A1 event criterion of PTSD in the DSM-IV 
(American Psychiatric Association, 1994) to include “the diagnosis of a life threatening 
disease” as potentially traumatizing, expanded the range of traumatic effects to include the 
patient’s interpersonal domain. Consequently, an individual’s witnessing of or learning 
about a significant person [to him/her] being diagnosed with a terminal illness is now 
viewed as potentially traumatizing. Family members and loved ones torturously stand by as 
their beloved endures periods of devastating illness effects, physical and psycho-spiritual 
pain, or highly invasive treatments that produce debilitating fatigue---all of which may be 
followed by uncertain terminal illness and possible death. Family members typically are 
involved in making hard calls or decisions regarding the patient, which, in itself, is a 
potential independent risk factor for PTSD (Azoulay et al., 2004, 2005).  
The psychological sequelae of childhood cancer in both the children and their parents are 
well documented, which consists of post-traumatic stress symptoms, anxiety, and 
depression (Kazak, 2005; Kazak et al., 2005). More specifically, the sequelae as to parental 
risk for affective and stress reactions range from 9% to 40% for the above disorders for a 
period of up to 3 years after the child’s diagnosis (Kazak et al., 2004; Stoppelbein & 
Greening, 2007). Barakat and colleagues found that the parents of childhood cancer 
survivors showed significantly higher levels of post-traumatic stress symptoms (PTSS) than 
a comparison group of parents (1997). Similarly, Kazak found significant elevation in PTSD 
scores in parents of survivors in contrast to parents of never-ill children (Kazak et al., 1997). 
Indeed, the line of research exploring distress in relatives of cancer survivors indicate that 
the relatives are usually at least as distressed as the cancer survivors (especially mothers)---if 
not more so (e.g., Couper et al., 2006; Mosher & Danoff-Burg, 2004; Tuinmann et al., 2004). 
Kazak and colleagues (2004) found current PTSD prevalence for parents of adolescent 
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survivors to be 13.7% for mothers and 9.6% for fathers. Lastly, an interesting finding in the 
literature demonstrating the parent-child relationship is that the ill child’s psychological 
adjustment to his/her cancer diagnosis and treatment is highly correlated with the parents' 
adjustment to their child’s diagnosis and treatment (Ljungman et al., 2003). 
7.2 The bereaved 
It has been estimated that for every person that dies five close friends or family members are 
affected (Zisook et al., 1998), therefore, the bereaved family and friends of cancer patients 
are at risk of developing psychological traumatic disorders as well as complicated grief. 
Indeed, the existing PTSD literature for the most part ignores bereaved individuals despite 
the fact that such individuals meet the A1 stressor criterion of the DSM (American 
Psychiatric Association, 1994). One of the few studies in this area investigated pre- and post-
loss bereavement levels of posttraumatic stress symptoms (intrusion and avoidance) in 50 
partners of women with metastatic/recurrent breast cancer as well as the relationship of 
these symptoms to past, current, and anticipatory stressors (Butler et al., 2005). The data 
indicated that 17 (34%) of the bereaved partners experienced clinically  
significant PTS symptom levels prior to the patients' deaths; specifically, prior to loss, 
partners' symptoms were positively associated with their current level of perceived stress 
and anticipated impact of the loss. However, following the death of the loved one, partners' 
posttraumatic stress symptoms were predicted by higher pre-loss levels of symptoms, past 
family deaths, and anticipated impact of the loss.  
A more recent study investigated PTSD and PTSD predictors in bereaved individuals who 
had experienced the loss of a close relative to cancer and were attending counseling (Elklit et 
al., 2010). A total of 251 bereaved relatives, with ages ranging from 14 to 76 (M = 41.3), were 
recruited at a counseling service that assisted cancer patients and their relatives. The 
findings indicated that the prevalence of current PTSD was 40% in this sample. 
Furthermore, hierarchical logistic regression analysis showed that the following variables 
moderated the risk for PTSD: full-time employment, perceived control, and a secure 
attachment style. An extended period of caretaking as well as high levels of somatization 
and dissociation also were associated with an increased risk of PTSD (Elklit et al., 2010). 
7.3 The forgotten children: Siblings 
As parents become distressed over the condition of their child diagnosed with cancer, they 
likely will spend extended periods of time at home or in the hospital attending to the needs 
of that child. As the stress of the malignant disease process takes its biopsychosocial toll on 
the child and the parents, the time will come, undoubtedly, when the adults will not be able 
to physically and emotionally meet the needs of their other children in the family (Alderfer 
& Kazak, 2006). It is not surprising, then, that the siblings of children with cancer become 
increasingly at risk for affective, behavioral, and school problems (Aldelfer & Hodges, 2010; 
Alderfer et al., 2010). Siblings of children with cancer experience feelings of anger, fear, 
grief, guilt, helplessness, insecurity, jealousy, loneliness, loss, resentment, and shock, (e.g., 
McGrath, 2001; Nolbris et al., 2007; Woodgate, 2006). Furthermore, investigations examining 
sibling distress increasingly indicate that a marked subset of siblings with a brother or a 
sister with cancer display post-traumatic stress (PTS) symptoms.  
One study investigated whether 78 adolescent siblings of childhood cancer survivors 
experience posttraumatic stress; the participants completed self-report measures of anxiety, 
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perceptions of the cancer experience, and posttraumatic stress (Alderfer et al., 2003). The 
findings showed that close to half of the sample (49%) reported mild posttraumatic stress, 
and more worrisome, that 32% indicated moderate to severe levels. Additionally, one-fourth 
of the siblings thought their brother/sister would die just during cancer treatment alone, 
and more than half of the sample viewed the experience of cancer as scary. These 
perceptions, not surprisingly, were found to be related to PTS. These siblings reported a 
greater number of PTS symptoms than did an adolescent comparison group who were not 
psychologically affected by their sibling’s illness, yet did report similar levels of general 
anxiety. Overall, studies that have investigated PTS reactions in siblings of children with 
cancer estimate that between 29–38% of the siblings exhibit moderate to severe cancer-
related PTS---which can occur years after the treatment for cancer has ended (Alderfer et al., 
2003; Packman et al., 2004). 
8. Risk factors for cancer – Related PTSD 
Many of the risk factors associated with adult cancer-related PTSD mirror the risk factors for 
PTSD from other traumas such as combat (e.g., Foy et al., 1987). Incidence and severity of 
cancer-related PTSD are affected by factors that occur before and during the cancer 
experience (Gurevich et al., 2002).  
8.1 Gender, age, and socio-economic status 
Pre-cancer factors, for example, gender, age, socio-economic status, and trauma history are 
associated with cancer-related PTSD. In terms of gender, female patients appear to be at 
greater risk for developing PTSD than their male counterparts (Kangas et al., 2002). Younger 
age at diagnosis also is a potential risk factor (Epping-Jordan et al., 1999; Kangas et al., 2002). 
Specifically, younger women may experience more distress due to the perception that 
cancer is more threatening to their lives; older women who have lived out the majority of 
their lifespan, on the other hand, may be less worried about recurrence, and thus display 
more positive mental adjustment (Glanz & Lerman, 1992). Socio-economic circumstances, 
specifically, lower income has been found to be associated with developing cancer-related 
PTSD; that is, it may be the case that fewer material resources combined with the stress of a 
cancer diagnosis may make the cancer experience more traumatic (Cordova et al., 1995).  
8.2 Personality, history, and disease characteristics 
Personality characteristics/traits such as neuroticism, pessimism, a pre-cancer history of 
affective disorders such as depression, or having a history of traumatic experiences may 
increase a patient’s vulnerability to developing PTSD in the context of cancer (Andrykowski 
& Cordova, 1998; Epping-Jordan et al., 1999; Glanz & Lerman, 1992). Ineffective and 
maladaptive coping strategies, for example, staunch avoidance regarding the diagnosis of 
cancer as well as a pre-cancer coping style of avoidance, have been linked with PTSD 
relating to cancer (e.g., Butler et al., 1999; Jacobsen et al., 2002). It is reasonable to expect that 
characteristics of the disease process, itself, may contribute to distress and suffering in the 
form of PTSD. Specifically, research shows that, indeed, risk increases for PTSD in the case 
of malignant recurrence or the more advanced the stage of the disease (e.g., Andrykowski & 
Cordova, 1998). Additionally, research suggests a greater likelihood of patients developing 
cancer-related PTSD when more aggressive or invasive treatments are used (Gurevich et al., 
2002).  
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8.3 Social support 
In 1979, Berkman and Syme published their seminal study linking social relationships to 
mortality. Three decades later, reliable links between social support and better physical 
health outcomes continue to be demonstrated, with epidemiological studies showing that 
those with low levels of social support have higher rates of mortality (Berkman et al., 2000; 
Uchino, 2004). Moreover, research indicates that social support is associated with improved 
immune function (e.g., Dixon et al., 2001; Lutgendorf et al., 2005). Thus, the possibility that 
social factors may be related to certain patients manifesting PTSD during the distress of 
cancer is congruent with this literature. Data have shown social support to be inversely 
associated with intrusive thoughts (DSM criterion B) and avoidance of cancer reminders of 
the cancer experience (DSM criterion C) (Andrykowski & Cordova, 1998; Jacobsen et al., 
2002). In women with metastatic breast cancer, the size of a woman’s emotional support 
network was found to predict avoidant symptoms in the patient (Butler et al., 1999). In 
terms of relational quality, a salient aspect of significant others in our lives is that of being 
supportive during times of personal disclosure, that is, the sharing of intimate information 
with trusted others. In the context of cancer, negative responses from others after a patient 
disclosed concerns and fears about her disease have been found to be associated with 
greater PTSD symptomatology (Cordova et al., 2001).  
The issue of quality of life is a major line of research in cancer populations. A study by 
Lewis and colleagues (2001) investigated the moderating effect of social support on the 
relationship between cancer-related intrusive thoughts and quality of life. Sixty-four breast 
cancer survivors (of unspecified time since diagnosis or treatment) completed self-report 
measures of: social support (disclosure of thoughts/feelings to significant others); cancer-
related intrusive thoughts; and, quality of life. After controlling for demographic and 
treatment variables, the appraised level of social support was found to moderate the 
negative impact of cancer-related intrusive thoughts on both physical and psychological 
quality of life measures. Specifically, no significant relationship was found for cancer-related 
intrusive thoughts and quality of life in women who had endorsed high levels of social 
support. For women with low levels of perceived support, however, the data revealed a 
significant and negative relationship between cancer-related intrusive thoughts and 
participants’ quality of life. These data suggest that appraised levels of social support in 
breast cancer patients may mitigate the impact of traumatic events during a woman’s 
distressing breast cancer experience (Lewis et al., 2001). In sum, research indicates that 
certain demographic, personal and/or historical characteristics as well as biopsychosocial 
factors contribute to the multifactorial process of a cancer patient’s experience. Data support 
the notion also that multiple factors appear to influence individual vulnerability and 
manifestation of posttraumatic symptoms in cancer patients. 
9. Conclusion 
Overall, findings regarding adult prevalence rates in adults with breast and mixed 
gender/mixed cancer types are consistent with previous estimates of current cancer-related 
PTSD prevalence in adult patients, that is, rates ranging from 0 to 32% (Hamann et al., 2005). 
Several points were highlighted. First, eight of the 11 studies identified in the summary 
review and listed in Table 3 involved women with breast cancer. Consequently, most of the 
present state of knowledge about PTSD in cancer patients is based upon this cancer 
population. Generalizability to other disease populations or to individuals diagnosed with 
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different types of cancer thus is limited. Additionally, all but two of the investigations were 
cross-sectional studies with variance regarding time from either diagnosis or treatment to 
the study when the assessments occurred. Cross-sectional data limits clinical usefulness and 
understanding about the trajectory patterns of PTSD in those with cancer; future studies that 
are prospective or longitudinal in design with large sample sizes are recommended. These 
findings stand in contrast to the surprising stark paucity of research as to psychological 
adjustment such as PTSD and risk or predictive factors in men with prostate cancer who end 
up needing a prostatectomy. Much more research in the future is needed imperatively in 
this area to fill this gap in the literature. Similarly, further research investigating PTSD and 
related factors with large sample sizes in pediatric populations are suggested. 
Over the past decade, increasing empirical evidence indicates that having a child diagnosed 
with a malignant disease process is psychologically traumatic for the parents. Specifically, 
symptoms of PTSD---the reexperiencing of traumatic events, physiologic arousal, and 
behaviors to avoid cues related to the cancer experience---have been documented in parents 
(especially mothers), whose children had completed cancer treatment (e.g., Brown et al., 
2004; Manne et al., 2004). One study involving 150 families of adolescent childhood cancer 
survivors 1 to 10 years after completing cancer treatment found that practically all of the 
families (99%) had at least one parent who met PTSD symptom criteria for reexperiencing 
(Kazak et al., 2004). Moreover, 20% of the families were found to have at least one parent 
who met criteria for being diagnosed with current PTSD.  
Research into posttraumatic stress in the bereaved and siblings of children with cancer were 
reviewed, with limited quantity and quality of studies noted. Large-scale epidemiological 
studies are needed to comprehensively estimate prevalence rates of posttraumatic stress for 
these emerging, psychologically affected populations. A severe absence of investigation 
exists regarding PTSD among the bereaved of a cancer patient, and adequate estimates of 
prevalence do not exist at this time. It must be emphasized that the absence of sufficient data 
in certain types of cancer populations---such as males with prostate cancer, the bereaved or 
sibling groups---limits intervention approaches and clinical efficacy. A plethora of well-
designed studies ultimately will enable targeted and successful interventions for those 
suffering with cancer-related PTSD. Only then, will clinical care truly be capable of 
providing the needed services for those traumatically affected by cancer. Members of the 
significant family-and-friends system need not struggle helplessly as they live with and 
function in the context of a “life-threatening” malignant illness. 
In closing, future investigations are needed in order to develop targeted, effective and 
appropriate psychological interventions to address PTSD in cancer patients as well as to 
educate them about coping with life in the context of cancer. This will be especially salient in 
the future, based on current philosophical and medical zeitgeist, as the number of cancer 
survivors continues to increase. 
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